- JORENBY D: Clinical efficacy of bupropion in the management of smokingcessation. Drugs (2002) 62\(Suppl. 2):25–35.
- •A comprehensive review of the efficacy of bupropion.
- DOLL R, PETO R, BOREHAM J, SUTHERLAND I: Mortality in relation to smoking: 50 years' observations on male British doctors. BE Med. (2004) 328:1519.
- EDWARDS R: The problem of tobacco smoking. Br. Med. J. (2004) 328:217–219.
- NATIONAL INSTITUTE OF CLINICAL EXCELLENCE: Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. NICE report (2002) No. 39.
- •UK guidelines on treatments for smoking cessation.
- NO AUTHORS LISTED: A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA (2000) 283:3244–3254.
- FAGERSTROM K: The epidemiology of smoking: health consequences and benefits of cessation. Drugs (2002) 62\(Suppl. 2):l–9.
- HAYS JT, EBBERT JO: Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits. CNS Drugs (2003) 17:71–83.
- LIGHTWOOD JM, PHIBBS CS, GLANTZ SA: Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics (1999) 104:1312–1320.
- LIGHT WOOD JM, GLANTZ SA: Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation (1997) 96:1089–1096.
- WARING WS: The role of pharmacotherapy in assisting smoking cessation. Eur. Clin. Pharmacy]. (2003) 59:351–356.
- SILAGY C, STEAD LF: Physician advice for smoking cessation. Cochrane Database Syst. Rev (2004) (4):CD000165.
- LANCASTER T, STEAD LF: Individual behavioural counselling for smoking cessation. Cochrane Database Syst. Rev (2005) (2):CD001292.
- RICE VH, STEAD LF: Nursing interventions for smoking cessation. Cochrane Database Syst. Rev (2004) (1):CD001188.
- SUTHERLAND G: Current approaches to the management of smoking cessation. Drugs (2002) 62\(Suppl. 2):53–61.
- WHITE AR, RAMPES H, ERNST E: Acupuncture for smoking cessation. Cochrane Database Syst. Rev (2002) (2):CD000009.
- SILAGY C, LANCASTER T, STEAD L, MANT D, FOWLER G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev (2004) (3):CD000146.
- HUGHES JR, STEAD LF, LANCASTER T: Antidepressants for smoking cessation. Cochrane Database Syst. Rev (2004) (4):CD000031.
- •Cochrane review of smoking cessation therapies.
- GOURLAY SG, STEAD LF, BENOWITZ NL. Clonidine for smoking cessation. Cochrane Database Syst. Rev (2004) (3):CD000058.
- HOLM KJ, SPENCER CM: Bupropion: a review of its use in the management of smoking cessation. Drugs (2000) 59:1007–1024.
- BALFOUR DJ: The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion. J. Clin.Pjct. (2001) 55:53–57.
- JOHNSTON AJ, ASCHER J, LEADBETTER R et al: Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation. Drugs (2002) 62\(Suppl. 2):11–24.
- TASHKIN D, KANNER R, BAILEY W et al.: Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet (2001) 357:1571–1575.
- HURT RD, SACHS DP, GLOVER ED et al.: A comparison of sustained-release bupropion and placebo for smoking cessation. NEIM (1997) 337:1195–1202.
- TONSTAD S, FARSANG C, KLAENE G et al:Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur. Heart J. (2003) 24:946–955.
- HALL SM, HUMFLEET GL, REUS VI, MUNOZ RE HARTZ DT, MAUDE-GRIFFIN R: Psychological intervention and antidepressant treatment in smoking cessation. Arch. Gen. Psychiatry (2002) 59:930–936.
- JORENBY DE, LEISCHOW SJ, NIDES MA et al.: A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. NEIM (1999) 340:685–691.
- HAYS JT, HURT RD, RIGOTTI NA, NIAURA R et al: Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomised, controlled trial. Ann. Intern. Med. (2001) 135:423–433.
- CHENGAPPA KN, KAMBHAMPATI RK, PERKINS K et al. Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants. J. Clin. Psychiatry (2001) 62:503–508.
- HAYFORD KE, PATTEN CA, RUMMANS TA et al.: Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br. Psychiatry (1999) 174:173–178.
- HERTZBERG MA, MOORE SD, FELDMAN ME, BECKHAM JC: A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. Clin. Psychopharmacol (2001) 21:94–98.
- EVINS AE, MAYS VK, RIGOTTI NA, TISDALE T, CATHER C, GOFF DC: A pilot trial of bupropion added to cognitive behavioural therapy for smoking cessation in schizophrenia. Nicotine Tob. Res. (2001) 3:397–403.
- WEINER E, BALL MP, SUMMERFELT A, GOLD J, BUCHANAN RW: Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. Am. I Psychiatry (2001) 158:635–637.
- HAYS JT: Tobacco dependence treatment in patients with heart and lung disease: implications for intervention and review of pharmacological therapy. I Cardiopulmon rehabil (2000) 20:215–223.
- ASCHER JA, COLE JO, COLIN JN, FEIGHNER JP, FERRIS RM, FIBIGER HC et al.: Bupropion: a review of its mechanism of antidepressant activity. Clin Psychiatry (1995) 56:395–401.
- BOSHIER A, WILTON LV, SHAKIR SA: Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000. Eur. j Clin Pharmacol (2003) 59:767–773.
- •Drug Safety Research Unit UK investigation of bupropion safety.
- AUBIN HJ: Tolerability and safety of sustained-release bupropion in the management of smoking cessation. Drugs (2002) 62\(Suppl. 2):45–52.
- COMMITTEE ON SAFETY OF MEDICINES: Zyban (bupropion) - safety reminder. Curr. Prob. Pharmacovig. (2001) 27:5.
- GODFREY C, FOWLER G: Pharmacoeconomic considerations in the management of smoking cessation. Drugs (2002) 62\(Suppl. 2):63–70.
- •A review of pharmacoeconomics of smoking cessation in the UK setting.
- PARROTT S, GODFREY C: Economics of smoking cessation. Br. Med. J. (2004) 328:947–949.
- BARENDREGT JJ, BONNEUX L, VAN DER MAAS PJ: The health care costs of smoking. NEIM (1997) 337:1052–1057.
- http://emc.medicines.org.uldemciassetsici htmliclisplaydoc.asp?documentid=2948 Zyban (SPC) (2005).
- http://medicines.mhra.gov.uldourworld monitorsafequalmedisafetymessagesi zyban26702.pdf CSM: Zyban safety update (2002).
Bupropion: risks and benefits
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.